This is a preview of subscription content, log in via an institution to check access.
Notes
Japanese yen
Reference
Saito S, et al. Cost-Effectiveness of Paclitaxel + Ramucirumab Combination Therapy for Advanced Gastric Cancer Progressing After First-Line Chemotherapy in Japan. Clinical Therapeutics : 23 Nov 2017
Rights and permissions
About this article
Cite this article
Paclitaxel + ramucirumab not cost effective for gastric cancer. PharmacoEcon Outcomes News 793, 26 (2017). https://doi.org/10.1007/s40274-017-4586-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-4586-3